In particular, it has been demonstrated that either chemotherapy or radiotherapy lead to HMGB1 release from dying cancer cells, promoting antigen processing and presentation on dendritic cells (DCs) through TLR4-MyD88 axis [133,134]. The gene discussed is HMGB1; the disease is cancer.